(Source: Business Wire, 01 March 2011)
Type 2 Diabetes Pipeline Review, Q4 2010, provides an overview of the Type 2 Diabetes therapeutic pipeline. This report provides information on the therapeutic development for Type 2 Diabetes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Type 2 Diabetes. Type 2 Diabetes-Pipeline Review 2010, Q4 2010 is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Read more
0 comments:
Post a Comment